[HTML][HTML] Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities

S Estes, K Konstantinov, JD Young - Current Opinion in Biotechnology, 2022 - Elsevier
Highlights•EVs come in two classes: native or engineered with defined therapeutic
entity.•Advances in engineering EVs to load cargo have enhanced potency.•High-density …

Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities

S Estes, K Konstantinov… - Current opinion in …, 2022 - pubmed.ncbi.nlm.nih.gov
Extracellular vesicles (EVs) have evolved across all phyla as an intercellular communication
system. There are intrinsic advantages of leveraging this capability to deliver therapeutic …

Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities.

S Estes, K Konstantinov, JD Young - Current Opinion in …, 2022 - europepmc.org
Extracellular vesicles (EVs) have evolved across all phyla as an intercellular communication
system. There are intrinsic advantages of leveraging this capability to deliver therapeutic …

[PDF][PDF] Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities

S Estes, K Konstantinov, JD Young - Current Opinion in …, 2022 - binasss.sa.cr
Extracellular vesicles (EVs) are lipid-bound particles secreted by both prokaryotic and
eukaryotic cells that contain a heterogeneous cargo of proteins, nucleic acids, and …

[PDF][PDF] Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities

S Estes, K Konstantinov, JD Young - Current Opinion in Biotechnology, 2022 - par.nsf.gov
Extracellular vesicles (EVs) have evolved across all phyla as an intercellular communication
system. There are intrinsic advantages of leveraging this capability to deliver therapeutic …

[引用][C] Manufactured extracellular vesicles as human therapeutics: challenges, advances, and opportunities

S Estes, K Konstantinov, JD Young - 2022